title: [Therapeutic efficacy of polyvalent immunoglobulins in autoimmune Lambert-Eaton's syndrome].
authors.forename: C
authors.initials: C
authors.lastname: Rose
authors.forename: E
authors.initials: E
authors.lastname: Hachulla
authors.forename: J F
authors.initials: JF
authors.lastname: Hurtevent
authors.forename: E
authors.initials: E
authors.lastname: Auxenfants
authors.forename: P Y
authors.initials: PY
authors.lastname: Hatron
authors.forename: B
authors.initials: B
authors.lastname: Devulder
mesh_terms: D000328:Adult; D001327:Autoimmune Diseases / Q000188:drug therapy*; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage / Q000627:therapeutic use*; D015624:Lambert-Eaton Myasthenic Syndrome / Q000188:drug therapy* / Q000276:immunology
chemical_list: D016756:Immunoglobulins, Intravenous
vernacular_title: Efficacité thérapeutique des immunoglobulines polyvalentes. Au cours d'un syndrome de Lambert-Eaton auto-immun.